BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Warning for snow and ice extended - 2What to watch for in weight loss drugs in 2026
- 3Manual for Financial plan Agreeable PC
- 4'War is not over': Detailed diagrams of prisons found in cells of Oct. 7 terrorists
- 5How much should a kid's birthday party cost? One mom spent $190 for pizza and ice cream at a park. Another paid $2K for a playspace and goodie bags.
- $2,000 tariff rebate checks? 50-year mortgages? Making sense of Trump's new 'affordability' proposals.
- Spain breaks jobs record with 22 million Social Security contributors
- How Trump's marijuana executive order could change medical research landscape
- Prehistoric wolf’s gut frozen in time reveals an ice age giant
- Jupiter and the moon take a sunset stroll on March 26. Here's how to see it
- Reclassifying Achievement: Individual Accounts of Seeking after Interests
- Von der Leyen: Paris meeting sends signal of unity for Ukraine
- Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'
- How do my eyes adjust to the dark and how long does it take?
